Craft

Sartorius

Stock Price

€194.4

2024-10-29

Market Capitalization

€15.3 B

2024-10-29

Revenue

€3.5 B

FY, 2025

Sartorius Summary

Company Summary

Overview
Sartorius is a life sciences company that specializes in biopharmaceutical research and drug development. It offers the development and production of cell lines, cell culture media and reagents, bioreactors, a variety of technologies for separation, purification and concentration of biological products, and other services.
Type
Public
Status
Active
Founded
1870
HQ
Göttingen, DE | view all locations
Website
https://www.sartorius.com/en
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Joachim Kreuzburg

    Joachim Kreuzburg, Chairman of the Executive Board and CEO

    • René Fáber

      René Fáber, Member of the Executive Board

    • Alexandra Gatzemeyer

      Alexandra Gatzemeyer, Member of the Executive Board

    • Petra Müller

      Petra Müller, Head of Investor Relations

      Operating MetricsView all

      Order Intake

      €2.2B
      124.0%

      Q3, 2023

      Production and Sales Sites

      60

      Q3, 2023

      Order Intake (Bioprocess Solutions)

      €1.7B
      132.0%

      Q3, 2023

      LocationsView all

      72 locations detected

      • Göttingen, NDS HQ

        Germany

        Otto-Brenner-Straße 20

      • Bohemia, NY

        United States

        565 Johnson Ave

      • Martínez, Provincia de Buenos Aires

        Argentina

        Cuyo 2889

      • Dandenong South, Victoria

        Australia

        Unit 5, 7-11 Rodeo Drive

      • Wien, Wien

        Austria

        Modecenterstraße 22/Top. Nr. D20 - D24

      • Bruxelles, Bruxelles

        Belgium

        Rue Colonel Bourg 105

      and 66 others

      Sartorius Financials

      Summary Financials

      Revenue (Q1, 2026)
      €899.1M
      Gross profit (Q1, 2026)
      €547.0M
      Net income (Q1, 2026)
      €81.0M
      Cash (Q1, 2026)
      €573.8M
      EBIT (Q1, 2026)
      €153.9M
      Enterprise value
      $19.1B

      Footer menu